Labcorp Acquires Certain BioReference Health Laboratory Assets for $237.5M
March 28, 2024
Labcorp will acquire certain laboratory testing businesses and operating assets from Opko Health subsidiary BioReference Health for $237.5 million. The assets — which generate roughly $100 million in annual revenue — include patient service centers and select customer contracts across the U.S. (excluding New York and New Jersey); BioReference Health will retain its oncology and urology diagnostic businesses and full operations in New York and New Jersey. The transaction is expected to close in the second half of 2024, subject to customary conditions and regulatory approvals.
- Buyers
- Labcorp
- Targets
- BioReference Health
- Sellers
- Opko Health, BioReference Health
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Labcorp Acquires MLM Medical Labs
September 8, 2026
Healthcare Services
Labcorp acquired MLM Medical Labs, a global central and specialty laboratory provider serving clinical trials and biopharmaceutical companies. The acquisition expands Labcorp’s international laboratory footprint and strengthens its biomarker and specialty testing capabilities; Great Point Partners sold its portfolio company.
-
Labcorp Acquires North Mississippi Health Services' Ambulatory Outreach Laboratory Business
April 21, 2025
Healthcare Services
Labcorp has completed the acquisition of North Mississippi Health Services' ambulatory outreach laboratory business and will become the referral laboratory for NMHS's seven hospitals and clinic laboratories. Labcorp plans to open three new patient service centers in Tupelo, West Point and Amory to increase access to laboratory services and provide continuity of care, data tools and expanded testing capabilities in North Mississippi.
-
Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B
July 8, 2024
Healthcare Services
Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.
-
Labcorp Acquires RWJBarnabas Health Outreach Laboratory Business
August 23, 2022
Healthcare Services
Labcorp has closed the acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets, expanding Labcorp’s diagnostic footprint and patient access across New Jersey. The deal transfers RWJBarnabas Health’s outreach testing operations to Labcorp to provide an expanded test menu, enhanced connectivity, and broader patient service coverage; terms were not disclosed.
-
Quest Diagnostics Acquires Labtech Diagnostics
December 14, 2021
Healthcare Services
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
-
Clinical Reference Laboratory Acquires Confirm BioSciences
December 9, 2020
Healthcare Services
Clinical Reference Laboratory (CRL), a large privately held clinical testing laboratory, has acquired Confirm BioSciences, a San Diego–based provider of screening tools and consumer-facing testing products. The acquisition will have Confirm operate as a subsidiary and is intended to expand CRL's lab testing and R&D capabilities while leveraging Confirm's large retail/customer base and COVID-19 testing pipeline.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.